In this rendering of the enzyme chondroitinase ABC, point mutations are represented by red balls. This re-engineered form of the enzyme is more stable and more active than the wild type and could be used to help reverse nerve damage caused by spinal cord injury or stroke. (From Hettiaratchi, O’Meara et al., 2020. DOI: 10.1126/sciadv.abc6378
A team of researchers from U of T Engineering and the University of Michigan has redesigned and enhanced a natural enzyme that shows promise in promoting the regrowth of nerve tissue following injury.
Their new version is more stable than the protein that occurs in nature, and could lead to new treatments for reversing nerve damage caused by traumatic injury or stroke.
“Stroke is the leading cause of disability in Canada and the third leading cause of death,” says University Professor Molly Shoichet (ChemE, BME, Donnelly), senior author on a new study published in the journal Science Advances.
“One of the major challenges to healing after this kind of nerve injury is the formation of a glial scar.”
A glial scar is formed by cells and biochemicals that knit together tightly around the damaged nerve. In the short term, this protective environment shields the nerve cells from further injury, but in the long term it can inhibit nerve repair.
About two decades ago, scientists discovered that a natural enzyme known as chondroitinase ABC — produced by a bacterium called Proteus vulgaris — can selectively degrade some of the biomolecules that make up the glial scar.
By changing the environment around the damaged nerve, chondroitinase ABC has been shown to promote regrowth of nerve cells. In animal models, it can even lead to regaining some lost function.
But progress has been limited by the fact that chondroitinase ABC is not very stable in the places where researchers want to use it.
“It’s stable enough for the environment that the bacteria live in, but inside the body it is very fragile,” says Shoichet. “It aggregates, or clumps together, which causes it to lose activity. This happens faster at body temperature than at room temperature. It is also difficult to deliver chondroitinase ABC because it is susceptible to chemical degradation and shear forces typically used in formulations.”
Various teams, including Shoichet’s, have experimented with techniques to overcome this instability. Some have tried wrapping the enzyme in biocompatible polymers or attaching it to nanoparticles to prevent it from aggregating. Others have tried infusing it into damaged tissue slowly and gradually, in order to ensure a consistent concentration at the injury site.
But all of these approaches are mere Band Aids — they don’t address the fundamental problem of instability.
In their latest paper, Shoichet and her collaborators tried a new approach: they altered the biochemical structure of the enzyme in order to create a more stable version.
“Like any protein, chondroitinase ABC is made up of building blocks called amino acids,” says Shoichet. “We used computational chemistry to predict the effect of swapping out some building blocks for others, with a goal of increasing the overall stability while maintaining or improving the enzyme’s activity.”
“The idea was probably a little crazy, because just like in nature, a single bad mutation can wreck the structure,” says Mathew O’Meara, a professor of computational medicine and bioinformatics at the University of Michigan, and co-lead author of the new paper.
“There are more than 1,000 links in the chain that forms this enzyme, and for each link you have 20 amino acids to choose from,” he says. “There are too many choices to simulate them all.”
To narrow down the search space, the team applied computer algorithms that mimicked the types of amino acid substitutions found in real organisms. This approach — known as consensus design — produces mutant forms of the enzyme that don’t exist in nature, but are plausibly like those that do.
In the end, the team ended up with three new candidate forms of the enzyme that were then produced and tested in the lab. All three were more stable than the wild type, but only one, which had 37 amino acid substitutions out of more than 1,000 links in the chain, was both more stable and more active.
“The wild type chondroitinase ABC loses most of its activity within 24 hours, whereas our re-engineered enzyme is active for seven days,” says Marian Hettiaratchi, the other co-lead author of the paper. A former postdoctoral fellow in Shoichet’s lab, Hettiaratchi is now a professor of bioengineering at the University of Oregon’s Phil and Penny Knight Campus for Accelerating Scientific Impact.
“This is a huge difference. Our improved enzyme is expected to even more effectively degrade the glial scar than the version commonly used by other research groups,” says Hettiaratchi.
The next step will be to deploy the enzyme in the same kinds of experiments where the wild type was previously used.
“When we started this project, we were advised not to try as it would be like looking for a needle in a haystack,” says Shoichet. “Having found that needle, we are investigating this form of the enzyme in our models of stroke and spinal cord injury to better understand its potential as a therapeutic, either alone or in combination with other strategies.”
Shoichet points to the multidisciplinary nature of the project as a key to its success.
“We were able to take advantage of the complementary expertise of the authors to bring this project to fruition, and we were shocked and overjoyed to be so successful,” she says. “It went well beyond our expectations.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Regrowth of nerve tissue following injury
- Macrophage potentiates the recovery of liver zonation and metabolic function after acute liver injuryon May 6, 2021 at 2:53 am
The liver is an exclusive organ with tremendous regenerative capacity. Liver metabolic functions exhibit spatial heterogeneity, reflecting liver zonation. The mechanisms controlling the proliferation ...
- Leukemia inhibitory factor regulates Schwann cell proliferation and migration and affects peripheral nerve regenerationon April 22, 2021 at 5:02 am
Dysregulated genes after peripheral nerve injury may modulate various types of cells and contribute to nerve repair and regeneration ... 12 µm thick sections. Tissue sections were exposed ...
- Topical drug regenerates, restores function of erectile nerves damaged by radical prostatectomyon April 19, 2021 at 5:13 pm
Researchers at Albert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common ...
- Novel drug regenerates erectile nerves damaged by prostate surgeryon April 19, 2021 at 9:18 am
When treatment was applied following a nerve crush injury, siRNA treatment enhanced nerve regeneration (regrowth) and restored nerve function as shown by cavernosometry, a test in which blood ...
- Novel drug regenerates erectile nerves damaged by prostate surgeryon April 18, 2021 at 5:00 pm
Researchers have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer.
Go deeper with Google Headlines on:
Regrowth of nerve tissue following injury
Go deeper with Bing News on:
Reversing nerve damage
- Suppression of neuropathic pain and comorbidities by recurrent cycles of repetitive transcranial direct current motor cortex stimulation in miceon May 6, 2021 at 1:12 pm
Transcranial, minimally-invasive stimulation of the primary motor cortex (M1) has recently emerged to show promise in treating clinically refractory neuropathic pain. However, there is a major need ...
- Tenet on HBO Max: That ending explained and all your questions answeredon May 5, 2021 at 6:24 am
Tenet is streaming now on HBO Max, as well as on Amazon, Apple TV and Google Play. Unlike in theaters, you can now turn on subtitles and rewind the confusing bits to figure what the heck's going on.
- SharpEar Supplement Reviews – A Detailed Report on the Ear Health Capsules!!on May 4, 2021 at 1:43 pm
Brand Partner Content by KISS PR Brand Story* SharpEar Supplement Reviews – Does Sam Olsen Natural Hearing Health Capsules SharpEar Really Works Or Scam? Hearing decline and loss can be caused by many ...
- Can Diabetes Cause Cataracts?on May 3, 2021 at 2:17 am
Diabetes is a condition in which your body doesn’t make enough insulin or doesn’t use insulin properly. Insulin is a hormone that allows sugar to enter the cells in your body. If your body has ...
- Scientists Hope to Use Stem Cells to Reverse Death in Controversial Studyon May 1, 2021 at 5:00 pm
Researchers seem to be setting their sights on increasingly lofty goals when it comes to the human body – from the world’s first human head transplant, to fighting aging, and now reversing ...